Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its fourth-quarter 2025 investor letter for the “Baird Chautauqua International and ...

Shares of Regeneron Pharmaceuticals Inc. REGN rallied 1.21% to $762.65 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.50% to ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Catie Matthews suggested that marketers should embrace artificial intelligence in their own lives.

Regeneron Pharmaceuticals (REGN) has recently drawn attention after a period where the share price showed mixed short term ...

Shares of Regeneron Pharmaceuticals Inc. REGN slid 1.62% to $741.92 Thursday, on what proved to be an all-around favorable ...

Here’s why we believe Regeneron Pharmaceuticals (REGN) stock merits attention as a value addition. Currently, it is trading almost 44% lower than its 1-year peak and is also priced at a PS multiple ...

Investors with a lot of money to spend have taken a bullish stance on Regeneron Pharmaceuticals (NASDAQ:REGN). And retail traders should know. We noticed this today when the positions showed up on ...

Investors with a lot of money to spend have taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN). And retail traders should know. We noticed this today when the positions showed up on ...